Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCTs031180091
JPRN-jRCTs031180091
Active, not recruiting
Phase 2

ongitudinal study for severe traumatic brain injury patients by positron emission tomography/computed tomography - Longitudinal study for sTBI patients by PET/CT

Yamaki Tomohiro0 sites60 target enrollmentJanuary 21, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsSevere traumatic brain injuryBrain injuryS099 L0NK

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Severe traumatic brain injury
Sponsor
Yamaki Tomohiro
Enrollment
60
Status
Active, not recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 21, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yamaki Tomohiro

Eligibility Criteria

Inclusion Criteria

  • •1\.Subjects who admitted in Rehabilitation Center for Traumatic Apallics Chiba by the cause of severe traumatic head injury (Maximum hospitalization 3 years)
  • •2\.Subjects who have medical stability and can perform examinations safely
  • •3\.Subjects who have provide informed consent of documents by themselves or legal representatives of their free will

Exclusion Criteria

  • •1\.Subjects who are below the age of 15
  • •2\.Subjects who are maintained in poor glycemic control
  • •3\.Subjects who are judged as not suitable for participation in this study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
ongitudinal study for severe traumatic head injury patients by positron emission tomography/computed tomographyTraumatic head injury
JPRN-UMIN000029531Chiba Ryogo Center10
Completed
Not Applicable
on-interventional study to evaluate neurotoxicity under adjuvant or palliative therapy with Oxaliplatin Omnicare for patients with colorectal carcinomaC18MedDRA - Colorectal carcinoma (10010036)Malignant neoplasm of colon
DRKS00007822OMNICARE Pharma GmbH179
Completed
Not Applicable
on-interventional study to evaluate neurotoxicity under therapy with Docetaxel Omnicare for patients with various tumor entitiesC50C34C61C44C16Malignant neoplasm of breastMalignant neoplasm of bronchus and lungMalignant neoplasm of prostateOther malignant neoplasms of skinMalignant neoplasm of stomach
DRKS00008183OMNICARE Pharma GmbH109
Completed
Not Applicable
on-interventional study to evaluate neurotoxicity under therapy with Paclitaxel Omnicare for patients with various tumor entitiesC56C50C34Malignant neoplasm of ovaryMalignant neoplasm of breastMalignant neoplasm of bronchus and lung
DRKS00008185OMNICARE Pharma GmbH83
Completed
Not Applicable
on-invasive follow-up assessment of brain involvement in Duchenne muscular dystrophy
NL-OMON33784eids Universitair Medisch Centrum51